HomeAgenda

PL BioScience GmbH

Company (SME/startup) / 中小企業・スタートアップ

www.pl-bioscience.com/Aachen, Germany
31 profile visits

About

PL BioScience GmbH is a pioneering German biotech company, founded in 2015 as a spin‑off from RWTH Aachen University by Dr. Hatim Hemeda and Christian Wilkes, specializing in the development and production of Human Platelet Lysate (HPL) – a human‑derived, xeno‑free alternative to animal serum like fetal bovine serum (FBS) – PL BioScience has rapidly established itself at the forefront of regenerative medicine and cell therapy.

In May 2025, PL BioScience introduced the world’s first artificial HPL, leveraging lab‑grown platelets sourced through a collaboration with South Korea’s DewCell Biotherapeutics. This marks a breakthrough toward fully scalable, donor‑independent, and ethically produced HPL .

Earlier in April 2025, they launched ELAREM Ultimate‑FD PLUS, the only gamma‑irradiated, fibrinogen‑depleted, GMP‑grade HPL product manufactured in Europe under patent protection

ドイツのバイオテクノロジー企業PL BioScienceは、ヒト血小板溶解物(HPL)と呼ばれるヒト血小板由来の細胞培養培地を提供しています。

技術の詳細については、www.pl-bioscience.com/elarem-technologyをご覧ください

Social media

Business Type / 業種

R&D / 研究開発Reagents / 試薬提供

Disease Area / 疾患領域

Oncology / がんImmunology / 免疫・炎症Musculoskeletal System / 筋骨格系Dermatology and sensory system / 皮膚・感覚器

Business Domain / 分野

Medical devices / 医薬機器

Modalities / モダリティ

Cell therapy /細胞治療

Technologies / 技術

Cell cultivation system and 3D-bioprinter / 細胞培養装置、3Dバイオプリンター

Additional questions

Researched company/organisation type / マッチングご希望企業・機関のタイプ

Companies and Academia etc. (Joint research and development purpose) / 企業やアカデミア等(共同での研究、開発を目的)Major pharma etc. (Out-licensing purpose) / 大手ファーマ等(アウトライセンスを目的)Consultants, Agents, etc. (Supporting overseas business development) /コンサルタント、代理店等(海外での事業展開支援などを目的)

Researched disease area / マッチングご希望の疾患領域

Dermatology and sensory system / 皮膚・感覚器Others /その他

Researched Modality / マッチングご希望のモダリティ

Cell therapy / 細胞治療

Researched Technologies / マッチングご希望の技術

Cell cultivation system and 3D-bioprinter/ 細胞培養装置、3Dプリンター

Marketplace (1)